Huakang Biomedical Holdings Co Ltd
HKEX:8622
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| HK |
H
|
Huakang Biomedical Holdings Co Ltd
HKEX:8622
|
180.2m HKD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.6B USD |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
30.2B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
108.5B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.3B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
40.9B CNY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF |
Loading...
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
6.7T KRW |
Loading...
|
Market Distribution
| Min | -239 513 300% |
| 30th Percentile | -12.9% |
| Median | 0.5% |
| 70th Percentile | 5.3% |
| Max | 203 056% |
Other Profitability Ratios
Huakang Biomedical Holdings Co Ltd
Glance View
Huakang Biomedical Holdings Co. Ltd. operates as a medical group company. The company employs 83 full-time employees The company went IPO on 2018-12-13. The IVD reagents include male fertility IVD reagents, Epstein-Barr virus antibody detection reagents ad parasite antibody detection reagents, among others. The male fertility IVD reagents include sperm function test products, accessory genital glands test products, anti-sperm antibody test products, as well as male reproductive tract infection test products, among others. In addition, the Company is also involved in the sale of auxiliary reproductive supplies and equipments, such as glass coverslips and sperm sample collection cups.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Huakang Biomedical Holdings Co Ltd is -18.4%, which is in line with its 3-year median of -18.4%.
Over the last 3 years, Huakang Biomedical Holdings Co Ltd’s Net Margin has decreased from -12.1% to -18.4%. During this period, it reached a low of -24.3% on Jun 30, 2024 and a high of -9.2% on Sep 30, 2022.
